Serum levels of soluble interleukin-2 receptor
β Scribed by Yosef Uziel; Bernice R. Krafchik; Brian Feldman; Earl D. Silverman; Laurence A. Rubin; Ronald M. Laxer
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 414 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Jose Β΄Rodriguez, M.D. ## RESULTS. At presentation, a relationship was observed between advanced tumor (T) classification and high serum levels of CRP (P Γ 0.0015) and s-IL-2-R (P Γ΅ Head and
Background. In a variety of non-Hodgkin lymphomas, a correlation between soluble interleukin-2 receptor levels (sIL-2R) and clinical stage is demonstrable. In mycosis fungoides (MF), two findings raise the question as to a similar correlation: (1) a proportion of tumor cells express IL-2 receptor an
Background. Serum concentrations of soluble interleukin-2 receptor (IL-2R) were found to be high in patients with autoimmune diseases, lung cancer, malignant lymphoma, tuberculosis, and other diseases. Serum-soluble IL-2R was evaluated as a tumor maker in patients with gastric cancer. Methods. Preo
Soluble interleukin-2 receptor (sIL-2R) was measured in the plasma of 31 patients with idiopathic thrombocytopenic purpura (ITP) and 22 normal controls. When thrombocytopenia persisted longer than 6 months, the diagnosis of chronic ITP was made. Twenty patients had acute ITP, 11 patients had chronic